FDA Drugs (New Approvals & NDA)Original article
FDA/Center for Research on Complex Generics (CRCG) Workshop on Long-Acting Injectable (LAI) Generics: Advancing Innovation in Product Development and Regulatory Assessment - 12/01/2026
ConferenceNeutral
AI Analysis
Summary
The FDA is hosting a 2-day hybrid workshop on December 1, 2026 to address scientific and regulatory challenges in long-acting injectable generic drug development, bringing together FDA, industry, and academic experts.
Importance:3/10
Sentiment:
0.00
FDAWorkshopLong-Acting InjectableGenericsRegulatoryDrug Development
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 29, 2026 7:26 PM